Winssinger Frederic J 4

What Happened

• Frederic J. Winssinger, a director of USANA Health Sciences (USNA), had 1,058 restricted stock units (RSUs) convert into 1,058 shares on January 22, 2026 (reported on a Form 4 filed Jan 26, 2026). The filing shows an acquisition via exercise/conversion (code M) of 1,058 shares (price N/A) and a simultaneous disposition of 1,058 shares at $0.00.
• The conversion represents vested RSUs rather than an open-market purchase or a sale for cash. The $0.00 disposition typically indicates shares were surrendered/withheld (no cash proceeds shown), commonly to satisfy tax-withholding obligations related to vesting.

Key Details

• Transaction date: January 22, 2026; Form 4 filed January 26, 2026.
• Acquired: 1,058 shares via exercise/conversion of derivative (code M) — price listed as N/A.
• Disposed: 1,058 shares at $0.00 (derivative); no cash proceeds reported.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 — each RSU represents a contingent right to one share; F2 — these RSUs vest in 25% increments on 7/24/2025, 10/23/2025, 1/22/2026, and 4/23/2026.
• Filing timeliness: transaction reported on Jan 22 and filed Jan 26; confirm timeliness against Form 4 two-business-day rule if this matters to you.

Context

• This was a vesting/conversion of restricted stock units (compensation award), not an open-market buy or a headline sale. Such conversions are routine and typically reflect compensation vesting rather than a director taking a market position.
• The simultaneous disposal at $0.00 is consistent with shares withheld to cover taxes or other withholding obligations upon vesting; it does not indicate a market sale for cash proceeds.